US: FDA approves first cancer drug based on genetics of patient

Al Jazeera English 2017-08-31

Views 107

For decades the promise of manipulating the human genome to fight deadly diseases like cancer has seemed just out of reach.

Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Novartis shares jump on breast cancer drug trials success - 1breakingnews.com
play
01:43

Novartis shares jump on breast cancer drug trials success - 1breakingnews.com
Novartis anti-cancer drugs to cost less
play
01:22

Novartis anti-cancer drugs to cost less
Novartis loses patent battle in SC over its cancer drug
play
05:42

Novartis loses patent battle in SC over its cancer drug
SC dismisses plea of Novartis AG for patent of its cancer drug Glivec
play
01:16

SC dismisses plea of Novartis AG for patent of its cancer drug Glivec
Disappointed with SC verdict on Glivec Cancer Drug : Novartis
play
07:43

Disappointed with SC verdict on Glivec Cancer Drug : Novartis
SC rejects Novartis plea on Cancer drug patent - Emi Sethura Linga
play
01:03

SC rejects Novartis plea on Cancer drug patent - Emi Sethura Linga
Novartis Skips Weight Loss Drug 'Frenzy,' Focuses on 'Unique Position' for Cancer, Alzheimers, and Parkinsons Treatments
play
00:29

Novartis Skips Weight Loss Drug 'Frenzy,' Focuses on 'Unique Position' for Cancer, Alzheimers, and Parkinsons Treatments
Anti cancer drug SC to hear Novartis patent case
play
02:04

Anti cancer drug SC to hear Novartis patent case
SC rejects Novartis plea on Cancer drug patent - Emi Sethura Linga
play
01:03

SC rejects Novartis plea on Cancer drug patent - Emi Sethura Linga
Novartis Gets FDA Approval for New Antibiotic; Medtronic Reduces Water and Energy Use; World Spa and Well Being Conference Opens in Bangkok - Health Minute for September 14, 2012
play
01:42

Novartis Gets FDA Approval for New Antibiotic; Medtronic Reduces Water and Energy Use; World Spa and Well Being Conference Opens in Bangkok - Health Minute for September 14, 2012
Novartis, U.S. drug regulator agree to malaria drug trial against COVID-19
play
01:07

Novartis, U.S. drug regulator agree to malaria drug trial against COVID-19
Novartis cuts more jobs on drug setback
play
00:25

Novartis cuts more jobs on drug setback